Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line

Brain Res. 2001 Aug 31;912(1):99-104. doi: 10.1016/s0006-8993(01)02723-8.

Abstract

Previous studies from this laboratory have demonstrated that fibroblast growth factor 1 together with a number of co-activator molecules (dopamine, TPA, IBMX/forskolin), will induce the expression of the catecholamine biosynthetic enzyme tyrosine hydroxylase (TH) in 10% of human neurons (hNTs) derived from the NT2 cell line [10]. In the present study, we found that TH induction was increased to nearly 75% in hNTs when cells were permitted to age 2 weeks in culture prior to treatment with the differentiation cocktail. This high level of TH expression was sustained 7 days after removal of the differentiating agents from the media. Moreover, the induced TH present in these cells was enzymatically active, resulting in the production of low levels of dopamine (DA) and its metabolite DOPAC. These findings suggest that hNTs may provide an important tissue culture model for the study of factors regulating TH gene expression in human neurons. Moreover, hNTs may serve, in vivo, as a source of human DA neurons for use in transplantation therapies.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Cell Differentiation / drug effects*
  • Cell Differentiation / physiology
  • Colforsin / pharmacology
  • Culture Techniques
  • Dopamine / biosynthesis*
  • Dopamine / pharmacology
  • Fibroblast Growth Factor 1 / pharmacology
  • Humans
  • Immunohistochemistry
  • Models, Biological*
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / enzymology
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / enzymology
  • Parkinson Disease / metabolism
  • Parkinson Disease / physiopathology
  • Phosphodiesterase Inhibitors / pharmacology
  • Tissue Plasminogen Activator / pharmacology
  • Tyrosine 3-Monooxygenase / drug effects*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Phosphodiesterase Inhibitors
  • 3,4-Dihydroxyphenylacetic Acid
  • Fibroblast Growth Factor 1
  • Colforsin
  • Tyrosine 3-Monooxygenase
  • Tissue Plasminogen Activator
  • 1-Methyl-3-isobutylxanthine
  • Dopamine